Saksena; Anil K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Saksena; Anil K..The latest application filed is for "novel peptides as ns3-serine protease inhibitors of hepatitis c virus".

Company Profile

0.37.24

Saksena; Anil K. - Upper Montclair NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2	2012-04-03
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 8,067,379 - Bennett , et al. November 29, 2	2011-11-29
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ; et al.	2011-05-19
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,432,268 - Guzi , et al. October 7, 2	2008-10-07
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,425,576 - Arasappan , et al. September 16, 2	2008-09-16
Inhibitors of hepatitis C virus NS3 protease Grant 7,423,058 - Bogen , et al. September 9, 2	2008-09-09
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2	2007-07-17
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20070142300 - Arasappan; Ashok ; et al.	2007-06-21
Novel inhibitors of Hepatitis C virus NS3 protease App 20070142301 - Bogen; Stephane L. ; et al.	2007-06-21
Inhibitors of hepatitis C virus NS3 protease Grant 7,205,330 - Bogen , et al. April 17, 2	2007-04-17
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,186,747 - Arasappan , et al. March 6, 2	2007-03-06
Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease App 20070042968 - Bennett; Frank ; et al.	2007-02-22
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ; et al.	2007-02-08
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2	2007-01-30
17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,138,396 - Guzi , et al. November 21, 2	2006-11-21
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 7,115,578 - Ganguly , et al. October 3, 2	2006-10-03
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ; et al.	2006-09-14
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060069103 - Guzi; Timothy J. ; et al.	2006-03-30
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2	2006-03-14
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060014755 - Guzi; Timothy J. ; et al.	2006-01-19
Novel inhibitors of hepatitis C virus NS3 protease App 20050267043 - Bogen, Stephane L. ; et al.	2005-12-01
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20050245458 - Arasappan, Ashok ; et al.	2005-11-03
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ; et al.	2005-08-11
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,924,270 - Ganguly , et al. August 2, 2	2005-08-02
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 6,903,102 - Guzi , et al. June 7, 2	2005-06-07
Compounds as NS3-serine protease inhibitors of hepatitis C virus Grant 6,894,072 - Arasappan , et al. May 17, 2	2005-05-17
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050059606 - Saksena, Anil K. ; et al.	2005-03-17
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20050004053 - Ganguly, Ashit K. ; et al.	2005-01-06
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ; et al.	2004-12-16
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 6,800,434 - Saksena , et al. October 5, 2	2004-10-05
Compounds useful for inhibition of farnesyl protein transferase App 20040157872 - Cooper, Alan B. ; et al.	2004-08-12
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040132736 - Guzi, Timothy J. ; et al.	2004-07-08
Compounds useful for inhibition of farnesyl protein transferase Grant 6,689,789 - Cooper , et al. February 10, 2	2004-02-10
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,673,775 - Ganguly , et al. January 6, 2	2004-01-06
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ; et al.	2003-11-20
Novel compounds as NS3-serine protease inhibitors of hepatitis C virus App 20030207861 - Arasappan, Ashok ; et al.	2003-11-06
Compounds useful for inhibition of farnesyl protein transferase App 20030092726 - Cooper, Alan B. ; et al.	2003-05-15
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030036501 - Saksena, Anil K. ; et al.	2003-02-20
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20030004119 - Ganguly, Ashit K. ; et al.	2003-01-02
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ; et al.	2002-10-31
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,403,564 - Ganguly , et al. June 11, 2	2002-06-11
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20020055473 - Ganguly, Ashit K. ; et al.	2002-05-09
Compounds useful for inhibition of farnesyl protein transferase App 20010039283 - Cooper, Alan B. ; et al.	2001-11-08
5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon Grant 6,277,830 - Ganguly , et al. August 21, 2	2001-08-21
Compounds useful for inhibition of farnesyl protein transferase Grant 6,239,140 - Cooper , et al. May 29, 2	2001-05-29
Soluble azole antifungal salt Grant 5,883,097 - Lovey , et al. March 16, 1	1999-03-16
Tetrahydrofuran antifungals Grant 5,714,490 - Saksena , et al. February 3, 1	1998-02-03
Tetrahydrofuran antifungals Grant 5,710,154 - Saksena , et al. January 20, 1	1998-01-20
Tetrahydrofuran antifungals Grant 5,693,626 - Saksena , et al. December 2, 1	1997-12-02
Tetrahydrofuran antifungals Grant 5,661,151 - Saksena , et al. August 26, 1	1997-08-26
Nikkomycin analogs Grant 5,618,793 - Cooper , et al. April 8, 1	1997-04-08
Process for preparing intermediates for the synthesis of antifungal agents Grant 5,403,937 - Saksena , et al. April 4, 1	1995-04-04
Anti-fungal agents Grant 5,238,926 - Cooper , et al. August 24, 1	1993-08-24
Anti-fungal agents Grant 5,236,900 - Cooper , et al. August 17, 1	1993-08-17
Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof Grant 5,039,676 - Saksena , et al. August 13, 1	1991-08-13
Processes for preparation of cyclopentyl purine derivatives Grant 5,015,739 - Saksena , et al. * May 14, 1	1991-05-14
Process for preparing cyclopentyl purine derivatives Grant 4,999,428 - Saksena , et al. March 12, 1	1991-03-12
Method for treating allergic reactions with Forskolin Grant 4,782,082 - Kreutner , et al. November 1, 1	1988-11-01
Topical Treatment of hyperproliferative skin diseases Grant 4,696,946 - Green , et al. September 29, 1	1987-09-29
Method for treating allergic reactions with forskolin Grant 4,517,200 - Kreutner , et al. May 14, 1	1985-05-14
Triazolo [4,5-d]-pyrimidines Grant 4,076,711 - Ganguly , et al. February 28, 1	1978-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.